 CAMBRIDGE, Mass., Nov. 01, 2022 GLOBE NEWSWIRE -- Cullinan Oncology, Inc. Nasdaq: CGEM Cullinan Oncology a biopharmaceutical company focused on modality-agnostic targeted oncology for patients with cancer, today announced that its management team will participate in the following investor conferences. 